BOLD
Boundless Bio, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:58 PM EST
2.39USD-0.830%(-0.02)153,052
After-hoursNov 18, 2026 4:00:30 PM EST
2.40USD+0.418%(+0.01)
Loading…
Loading…
56.43M
Sector
Healthcare
Industry
Biotechnology
HQ
CA, USA
152
Previous Close
$2.41
Beta
-0.06
52-Week High
$3.16 2026-08-24
52-Week Low
$0.96 2026-02-05
SMA 50
$2.54
SMA 200
$1.99
Avg. Vol 10D
91,136
Avg. Vol 30D
142,282
Avg. Vol 90D
161,881
Relative Vol
1.08
23.61M
18.17M
76.94%
790,294
4.52%
5.06
61%/39%
44.19%
34.65%
4.3000%
2,700,000
6,677
3,265
6,677
-55.5M
-2.46
-57.4M
-64.57
Nov 18, 2026
Boundless Bio director Kevin Tang buys $33,148 in stock ·
Investing.com
Nov 11, 2026
Second Look at Local Housing Markets in October ·
Calculated Risk
Boundless Bio director Kevin Tang buys $4,677 in stock ·
Investing.com
Nov 10, 2026
Nov 9, 2026
BOLD Profile
Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects.
BOLD Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.46 | 2026-11-12 | -2.85% | 2.546 |
| 1M | 2.31 | 2026-10-19 | +3.46% | 0.384 |
| 3M | 2.86 | 2026-08-19 | -16.43% | 0.351 |
| 6M | 1.40 | 2026-05-19 | +70.71% | -0.745 |
| 1Y | 1.15 | 2025-11-19 | +107.83% | -0.060 |
| 2Y | 2.69 | 2024-11-19 | -11.15% | — |
| 5Y | 59.97 | 2020-01-14 | -96.02% | 0.930 |
BOLD Stock Summary
Boundless Bio, Inc. Common Stock (NASDAQ:BOLD) stock price today is $2.39, and today's volume is 153,052. BOLD is down 0.830% today. The 30 day average volume is 142,282. BOLD market cap is $56.43M with 23.61M shares outstanding.
